1. Champlin, R., Khouri, I., Anderlini, P., De Lima, M., Hosing, C., McMannis, J., et al. (2003). Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation: Biology and current indications. Oncology, 17:94–100.
2. Chunduri, S., Dobogai, L.C., Peace, D., Saunthararajah, Y., Chen, H.Y., Mahmud, N., et al. (2006). Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant, 38:477–482.
3. Ciurea, S.O., Anderssen, B.S. (2009). Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 15:523–536.
4. Giralt, S., Ballen, K., Rizzo, D., Bacigalupo, A., Horowitz, M., Pasquini, M., et al. (2009). Reduced intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant, 15:367–369.
5. Al-Ali, H., Cross, M., Lange, T., Freund, M., Dolken, G., Niederwieser, D., et al. (2009). Low-dose total body irradiation-based regimens as preparative regimens for allogeneic haematopoietic cell transplantation in acute myelogenous leukemia. Curr Opin Oncol, 21(Suppl 1), S17–S22.